References
- Ankier SI, Neat ML. (1972). Some studies on acute inflammation induced by dextran in the mouse. Int Arch Allergy Appl Immunol. 42:264–77
- Baron JA, Sandler RS. (2000). Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med. 51:511–23
- Brito AR, Antonio MA. (1998). Oral anti-inflammatory and antiulcerogenic activities of a hydroalcoholic extract and partitioned fractions of Turnera ulmifolia (Turneraceae). J Ethnopharmcol. 61:215–28
- Chang GJ. (2006). Thirteen week oral (gavage) toxicity of meso-zeaxanthin in Hans Wistar rats with a four-week recovery. Cambridge, UK: Howard Foundation, Study no. 1567--–4370
- Chau TT. (1989). Analgesic testing in animals models. In: Chang JY, Lewis AJ, ed. Pharmacological Methods in the Control of Inflammation. New York: Alan R. Liss, Inc., 195–212
- Coussens LM, Werb Z. (2002). Inflammation and cancer. Nature. 420:860–7
- Firdous AP, Preethi KC, Kuttan R. (2010). Antioxidant potential of meso-zeaxanthin a semi-synthetic carotenoid. Food Chem. 119:1096–101
- Firdous AP, Sindhu ER, Ramnath V, Kuttan R. (2011). Anti-mutagenic and anti-carcinogenic potential of the carotenoid meso-zeaxanthin. Asian Pac J Cancer Prev. 11:1795–800
- Firdous AP, Kuttan R. (2012). Amelioration of cisplatin-induced toxicity in mice by carotenoid meso-zeaxanthin. Hum Exp Toxicol. 31:710–17
- Firdous AP, Sindhu ER, Ramnath V, Kuttan R. (2013a). Amelioration of radiation-induced damages in mice by carotenoid meso-zeaxanthin. Int J Radiat Biol. 89:171–81
- Firdous AP, Sindhu ER, Ramnath V, Kuttan R. (2013b). Anti-carcinogenic activity of meso-zeaxanthin in rodents and its possible mechanism of action. Nutr Cancer. 65:850–6
- Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate and nitrite and (15-N) nitrite in biological fluids. Anal Biochem. 126:131–8
- Grivennikov SI, Greten FR, Karin M. (2010). Immunity, inflammation and cancer. Cell. 140:883–99
- Gupta RA, DuBois RN. (2001). Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 1:11–21
- Kundu JK, Surh YJ. (2008). Inflammation: Gearing the journey to cancer. Mutat Res. 659:15–30
- Licastro F, Candore G, Lio D, et al. (2005). Innate immunity and inflammation in ageing: A key for understanding age-related diseases. Immun Ageing. [Epub ahead of print]. doi:10. 1186/1742-4933-2-8
- Lin DT, Subbaramaiah K, Shah JP, et al. (2002). Cyclooxygenase-2: A novel molecular target for the prevention and treatment of head and neck cancer. Head Neck. 24:792–9
- Maity TK, Mandal SC, Mukherjee PK. (1988). Studies on anti-inflammatory effect of Cassia tora leaf extract (Fam. Leguminosae). Phytother Res. 12:221–4
- Merlos M, Gomez LA, Vericat L, et al. (1990). Comparative study of the effect of CV-6209, a specific PAF antagonist, on paw edema caused by different phlogogen agents. Pharmacology. 40:211–17
- Steele VE, Hawk ET, Viner JL, Lubert RA. (2003). Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer. Mutat Res. 523:137–44
- Wheeler AH, Cowan A. (1991). Neurogenic and tissue mediated components of formalin-induced edema: Evidence for supraspinal regulation. Agents Actions. 34:264–9
- Winter CA, Risly EA, Nuss CW. (1962). Carrageenan induced paw edema in hind paw of the rats – An assay for its anti-inflammatory drugs. Proc Soc Exp Biol Med. 11:544–7
- Yoshimura A. (2006). Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 97:439–47